Advertisement

All News

    Chemoimmunotherapy Responses May Allow for Omission of Radiotherapy in Lymphoma

    June 19th 2023

    Patients with a subtype of lymphoma may be able to exclude radiotherapy if they respond to chemoimmunotherapy, although more follow-up is needed to assess potential long-term toxicities.

    FDA Oncology Approval From Spring 2023

    June 19th 2023

    Here’s an overview of the new cancer regimens that gained Food and Drug Administration (FDA) approval in the spring of this year.

    The Importance of Age- and Disease-Specific Cancer Support

    June 19th 2023

    I learned that finding the right kind of support during and after a cancer diagnosis is truly invaluable.

    The Emerging Importance of Immunotherapy in Endometrial Cancer

    June 19th 2023

    Researchers are looking for other ways to disrupt tumor cells in a way that better engages the immune system by exposing it to tumor antigens.

    Educated Patient® MPN Summit Novel Drugs And Combinations for MF Presentation: May 20, 2023

    June 19th 2023

    Watch Dr. John O. Mascarenhas, from Icahn School of Medicine, discuss novel therapies in myelofibrosis during the CURE® Educated Patient® MPN Summit.

    Educated Patient® MPN Summit Risk Stratification and Management of MF Presentation: May 20, 2023

    June 18th 2023

    Watch Dr. Rami Komrokji, from Moffitt Cancer Center, discuss risk stratification and management of myelofibrosis during the CURE® Educated Patient® MPN Summit.

    The ‘New Normal’ of Food After Chemo

    June 17th 2023

    While my taste buds have returned to normal after cancer treatment, my desire to cook and eat has not.

    Educated Patient® MPN Summit Polycythemia Vera Panel: May 20, 2023

    June 17th 2023

    Watch Dr. Nikolai Podoltsev, Dr. Jerry Spivak and Amy Lane answer questions about polycythemia vera during the CURE® Educated Patient® MPN Summit.

    Adcetris Plus Opdivo and Chemo May Improve Treatment Response in Early-Stage Hodgkin Lymphoma

    June 16th 2023

    A significant majority of patients with early-stage classical Hodgkin lymphoma demonstrated a complete response to treatment with Adcetris, Opdivo and chemotherapy.

    Treating the Whole Patient With Cancer

    June 16th 2023

    Mental and emotional well-being are crucial to a person’s overall health, and they deserve plenty of attention from patients and providers alike.

    The Inequity of Cancer Survival

    June 16th 2023

    I’ve learned that “survivor’s guilt” can be another symptom of our disease.

    ‘Dark Knight’ Star Announces Cancer, Pope Francis Visits Oncology Ward and More

    June 16th 2023

    From Colin McFarlane and John Homme opening up about their cancer diagnoses to Pope Francis visiting a pediatric oncology ward, here’s what’s happening in the cancer space this week.

    FDA Approves Fixed-Duration Columvi to Treat Relapsed/Refractory DLBCL

    June 16th 2023

    Columvi is the first bispecific antibody that can be administered to patients with relapsed or refractory diffuse large B-cell lymphoma for a defined period of time.

    Educated Patient® MPN Summit On The Horizon For PV Management Presentation: May 20, 2023

    June 16th 2023

    Watch Dr. Jerry Spivak, from Johns Hopkins University School of Medicine, discuss what is on the horizon in the management of polycythemia vera during the CURE® Educated Patient® MPN Summit.

    Study Shows ‘A Lot of Hope’ for Prostate Cancer Treatment

    June 15th 2023

    Most patients with nonmetastatic castration-resistant prostate cancer were able to stay on their therapies long-term, research showed.

    ‘Gentleness And Kindness’ in the Lives of Patients With Cancer

    June 15th 2023

    Mindfulness meditation can make a big difference in the treatment experience of patients.

    Fighting Cancer is a Game of Adjustments

    June 15th 2023

    I remember hearing somewhere that there’s no such thing as achieving the perfect balance; rather, life itself is an act of constant rebalancing. I've found that to be true in life with cancer.

    Pre- or Post-Transplant Xospata Shows Relapse-Free Survival Benefit in AML Group

    June 15th 2023

    Findings from a phase 3 trial demonstrated that half of patients with FLT3-ITD-mutant acute myeloid leukemia and detectable minimal residual risk derived a relapse-free survival benefit with Xospata.

    Educated Patient® MPN Summit Current Management of PV Presentation: May 20, 2023

    June 15th 2023

    Watch Dr. Nikolai Podoltsev, from Yale School of Medicine, discuss the current management of polycythemia vera during the CURE® Educated Patient® MPN Summit.

    Surviving Four Cancer Diagnoses

    June 14th 2023

    I didn’t expect to be diagnosed with cancer, never mind end up with four diagnoses over the years. Here is what I learned along the way.

    Lining Up New Options for GIST

    June 14th 2023

    Patients with GIST have more treatment options than ever, with others currently under development.

    The Cancer Test Not Taken

    June 14th 2023

    Genetic testing is the norm for cancer patients with familial history. How did I let it slip through the crack?

    Treatment Breakthroughs: Immunotherapy Comes for Advanced Endometrial Cancer

    June 14th 2023

    Treatments for advanced endometrial cancer have progressed and improved with the use of immunotherapy with chemotherapy.

    Educated Patient® MPN Summit Essential Thrombocythemia Panel: May 20, 2023

    June 14th 2023

    Watch Dr. Lucia Masarova, Dr. Laura C. Michaelis and Celia Militz answer questions about essential thrombocythemia during the CURE® Educated Patient® MPN Summit.

    FDA Grants Capivasertib Plus Faslodex Priority Review for Breast Cancer

    June 13th 2023

    The application for capivasertib plus Faslodex in patients with HR-positive, HER2-negative locally advanced or metastatic breast cancer has also been granted priority review, meaning that the FDA has six months to make a decision.

    Non-English- Speaking Patients With Cancer Face Big Barriers to Care in the U.S., But Help Is Available

    June 13th 2023

    For patients who don’t speak English, there can be additional obstacles during their cancer journey. Resources, family, care providers, fellow patients and the law are on their side.

    Chemo Side Effects They Don’t Always Tell You About

    June 13th 2023

    When starting chemotherapy, I was expecting hair and weight loss, but was caught off guard when my mouth began to hurt.

    More CAR-T Cell Therapies Will ‘Ease Out the Shortage’

    June 13th 2023

    CAR-T cell therapies have not always been easy to access for patients with myeloma, though that is slowly changing, an expert explained.

    Educated Patient® MPN Summit Current Management and Trials on the Horizon in ET Presentation: May 20, 2023

    June 13th 2023

    Watch Dr. Laura C. Michaelis, from the Medical College of Wisconsin, discuss the current and future management of essential thrombocythemia during the CURE® Educated Patient® MPN Summit.

    Standard Approach for Inactive, Early CLL Remains a Wait-and-Watch Strategy

    June 12th 2023

    Patients with inactive early-stage chronic lymphocytic leukemia may benefit from a wait-and-watch approach compared with immediate treatment with Imbruvica, findings from a phase 3 trial showed.

    NEXT PAGE
    PREVIOUS PAGE
    Advertisement
    Advertisement